Expression of a Distinct Set of Chemokine Receptors in Adipose Tissue‐Derived Stem Cells is Responsible for In Vitro Migration Toward Chemokines Appearing in the Major Pelvic Ganglion Following Cavernous Nerve Injury  by Albersen, Maarten et al.
ORIGINAL RESEARCH—BASIC SCIENCE
Expression of a Distinct Set of Chemokine Receptors in Adipose
Tissue-Derived Stem Cells is Responsible for In Vitro Migration
Toward Chemokines Appearing in the Major Pelvic Ganglion
Following Cavernous Nerve Injury
Maarten Albersen, MD, PhD,*† Joost Berkers, MD,* Philip Dekoninck, MD,† Jan Deprest, MD, PhD,†
Tom F. Lue, MD,‡ Petter Hedlund, MD, PhD,§ Ching-Shwun Lin, PhD,‡ Trinity J. Bivalacqua, MD, PhD,¶
Hendrik Van Poppel, MD, PhD,* Dirk De Ridder, MD, PhD,* and Frank Van der Aa, MD, PhD*
*Laboratory of Experimental Urology, Department of Development and Regeneration, University of Leuven, Leuven,
Belgium; †Laboratory of Experimental Gynecology, Department of Development and Regeneration, University of Leuven,
Leuven, Belgium; ‡Knuppe Molecular Urology Laboratory, Department of Urology, University of California, San
Francisco, CA, USA; §Department of Urology, Urological Research Institute, Vita-Salute San Raffaele University, Milan,
Italy; ¶Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions,
Baltimore, MD, USA
DOI: 10.1002/sm2.1
A B S T R A C T
Introduction. Adipose tissue-derived stem cells (ADSCs) herald tremendous promise for clinical application in a
wide range of injuries and diseases. Several preclinical reports demonstrate their efﬁcacy in the treatment of
cavernous nerve (CN) injury-induced erectile dysfunction in rats. It was recently illustrated that these effects were
established as a result of ADSC migration to the major pelvic ganglion (MPG) where these cells induced
neuroregeneration in loco.
Aims. The study aims to identify chemotactic factors in the MPG following injury and to match upregulated
chemokines to their respective receptors in human ADSC on the genomic, structural, and functional levels.
Methods. Quantitative real-time polymerase chain reaction, ﬂuorescence-activated cell sorting (FACS), intracellular
FACS, immunoﬂuorescence microscopy, migration assays, and calcium imaging were used in this study.
Main Outcome Measures. The main outcomes are chemokine expression in the MPG following CN injury, and the
functional and structural presence of chemokine receptors in ADSC.
Results. CCR4, CX3CR1, and XCR1 are functionally and structurally present in human ADSC, and are activated by
the chemokines CCL2, CX3CL1, and XCL1 respectively, which are upregulated in the MPG following CN injury.
CXCR4 and its ligand CXCL12 (SDF1) are likely no major homing factors for ADSC. Expression of chemokine
receptor mRNA in ADSC did not necessarily translate into receptor presence at the cell surface and/or functional
activation of these receptors. Most of the expressed chemokine receptors were detected in the intracellular com-
partment of these cells.
Conclusions. We identiﬁed the ligand/chemokine receptor pairs CCL2/CCR4, CX3CL1/CX3CR1, and XCL1/
XCR1 as potentially responsible for ADSC homing toward the MPG following CN injury. The intracellular
localization of various chemokine receptors likely indicates redirecting of chemokine receptors to the cell surface
under speciﬁc cellular conditions. Furthermore, modiﬁcation of expression of these receptors at the genomic level
may potentially lead to improved migration toward injury sites and thus enhancement of treatment efﬁcacy.
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Introduction
Despite the development of nerve-sparingtechniques, neuropraxia of the cavernous
nerves (CNs), resulting in erectile dysfunction
(ED), remains a highly frequent complication of
radical prostatectomy for prostate cancer [1].
Various pharmacological “penile rehabilitation”
strategies have been investigated to prevent
denervation-induced smooth muscle apoptosis and
ﬁbrosis in the erectile tissue during the time frame
in which the injured CNs regenerate [2]. While
preclinical research was promising, recent clinical
trials have not uniformly conﬁrmed the beneﬁt of
penile rehabilitation in this setting. Therefore,
basic researchers have in the recent years been
focusing on stimulating CN regeneration follow-
ing neuropraxia, rather than aiming at the second-
arily damaged erectile tissue as a treatment target
[3]. In these studies, the application of multipotent
stromal cells (MSC) derived from either bone
marrow or adipose tissue has generated promising
results [4].
Kendirci and colleagues performed bilateral
CN crush injury in rats and injected bone marrow-
derived MSC (BM-MSC) and BM-MSC selected
for p75-nerve growth factor receptor expression
in the corpus cavernosum, resulting in beneﬁcial
effects on erectile recovery [5]. These authors sug-
gested paracrine effects on neuroregeneration
based on increased in vitro secretion of growth
factors by these stem cells. They noted an absence
of signiﬁcant cell incorporation and differentiation
into host cell types in the penis. This ﬁnding was
in line with previous studies regarding cellular
therapy for CN injury [4,6,7]. The repeated obser-
vation of erectile function improvement in the
absence of cell incorporation led to the hypothesis
that these cellular therapies may exert their effects
in a paracrine fashion [8]. In several consecutive
studies, our group has further investigated this
“paracrine hypothesis.” In an initiating study,
Albersen and coworkers injected either adipose
tissue-derived mesenchymal stem cells (ADSCs)
or ADSC-derived lysate in the corpus cavernosum
of CN-injured rats and observed preservation of
neuronal nitric oxide synthase content, diminished
smooth muscle apoptosis, and erectile tissue ﬁbro-
sis in both treated groups [9]. The lysate treatment
exposed injured tissues to soluble factors contained
in ADSC, without allowing live cells to incorpo-
rate in the host tissue, and thus supported
paracrine modes of action of stem cell therapy for
CN-injury induced ED [10]. This report was fol-
lowed by an experiment in which the major pelvic
ganglion (MPG), the autonomic ganglion from
which the CN originates, was cultured in condi-
tioned medium of either ADSC or smooth muscle
cells. Strongly enhanced neurite sprouting was
observed when these ganglia were cultured in
ADSC-conditioned media [11]. Results from the
latter experiment indicated that ADSCs secrete
substances that induce nerve regeneration. Fandel
et al. looked at the fate of EdU-labeled ADSC
after intracavernosal injection in the CN-injury rat
model, and observed a rapid decrease of cell
numbers from the injection site in the corpus
cavernosum following injection [12]. Surprisingly,
ADSC were located in the MPG in the ﬁrst days
following injury. Furthermore, this cell recruit-
ment proved essential for establishing beneﬁcial
effects of cell therapy, including enhanced
neuroregeneration and restoration of erectile
function. Increased expression of stromal cell-
derived factor 1 (SDF1; CXCL12) in the MPG
was noted and proposed as a possible homing
factor for ADSC following CN injury.
Aims
The gained results led us to conclude that recruit-
ment of ADSC toward the MPG is an essential
step in establishing the beneﬁcial effects of cellular
therapy. In this study, we therefore aimed to iden-
tify chemotactic factors in the MPG following
injury. Furthermore, we matched upregulated
chemokines to their respective receptors in human
ADSC on the genomic, structural, and functional
levels.
Methods
ADSC Isolation
After approval from the local ethical committee,
approximately 20 g of subcutaneous human
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adipose tissue was harvested from three informed
and consenting female adult patients undergoing
ureteral reimplantation for vesico-ureteral reﬂux.
Adipose tissue was rinsed in sterile calcium/
magnesium-free phosphate buffered saline (PBS),
minced into small pieces and digested by incuba-
tion in a solution containing 0.1% collagenase
type IA (Sigma-Aldrich, St. Louis, MO, USA) for
1 hour at 37°C with vigorous shake for 15 seconds
in 10-minute intervals. The top lipid layer was
removed and the remaining liquid portion was
centrifuged at 1,000 × g for 5 minutes at room
temperature. The remaining cells were suspended
in 10 mL Dulbecco’s modiﬁed Eagle medium
(DMEM) supplemented with streptomycin,
Amphotericin-B, penicillin, and 10% fetal bovine
serum (FBS). The suspension was ﬁltered through
a 70-μm cell strainer, plated at a density of
2–3 × 106 cells in a 75-cm2 dish, and cultured at
37°C in 5% CO2. After 24 hours, the cells were
rinsed with PBS to remove ﬂoating cells such as
blood cells. Cells were cultured until 90% conﬂu-
ence and split in a 1:4 ratio. Cells were then har-
vested by 3 minutes incubation in trypsin-EDTA
solution (Sigma-Aldrich) and used for further
study in passage 5.
Fluorescence-Activated Cell Sorting (FACS)
Human ADSC were examined for surface marker
expression by FACS. Cells were trypsinized,
washed in calcium/magnesium-free PBS contain-
ing 1% bovine serum albumin (FACS-buffer)
twice, and pelleted. Samples were incubated at 4°C
(CD markers) or room temperature (chemokine
receptors) for 30 minutes by the appropriate
primary anti-human antibody 1:25 in FACS-
buffer, followed by a double wash in FACS-buffer,
and resuspended in 400 μL PBS for ﬁnal analysis.
A minimimum of 10,000 events were recorded for
each analysis using a FACSort ﬂow cytometer (BD
Biosciences, Oxford, UK), and analyzed using cell
quest software (BD Biosciences). For chemokine
receptor expression, ADSCs were ﬁrst ﬁxed in 4%
paraformaldehyde, followed by washing in either
standard FACS-buffer (for surface chemokine
receptor detection), or by a washing step in
permeabilization buffer consisting of FACS-buffer
supplemented with 0.1% saponin (for intracellular
chemokine receptor detection). FACS was then
further conducted as described previously. CCRL1
and CCRL2 expression was assessed by a two-step
incubation as no conjugated primary antibodies
were available for these human epitopes. As a
negative control, cells were incubated with the
same species isotype controls as the primary anti-
bodies. Antibodies used included: anti-human
CD166-FITC (Acris, Herford, Germany);
CD14-PE; CD29-FITC; CD90-FITC (Biosource,
Camarillo, CA, USA); HLA-DR-PE; CD35-PE;
CD73-PE; HLA-ABC-FITC; CD44-PE (BD
Biosciences); CD45-PE; CD105-PE; CCR1-PE;
CCR3-FITC; CCR4-FITC; CCR7-FITC;
CCR10-FITC; CX3CR1-PE; XCR1-FITC;
CXCR4-PE; CXCR6-PE; CXCR7-PE (R&D
Systems, Abingdon, Oxon, UK); CCRL1; CCRL2
(1°, Abcam, Cambridge, UK); Gt anti-Rb-
IgG-FITC; Gt anti-mouse-IgG-PE (2°, R&D
Systems).
ADSC Differentiation
Differentiation capacity of ADSC toward
osteogenic lineage was tested by incubation in
DMEM supplemented with 10% FBS, 100 nM
dexamethasone, 0.2 mM ascorbic acid, and 10 mM
β-glycerol phosphate (all by Sigma-Aldrich) for
2.5 weeks. To assess calcium deposit formation;
cultures were stained with Alizarin Red.
Adipogenic differentiation was tested by cultur-
ing conﬂuent ADSC for 2.5 weeks in DMEM,
supplemented with 10% FBS, 0.5 mM isobutyl-
methylxanthine, 200 μg indomethacin, 1 μM
dexamethasone, 10 μg/mL insulin (all by Sigma-
Aldrich). After culture, cells were stained with
Oil-Red O solution.
Animal Study
Fourteen 12-week-old male Sprague-Dawley
rats were subjected to bilateral CN crush injury
under isoﬂurane 2% as previously described [13].
Twenty-four hours following injury, the bilateral
MPG was harvested and the animals were
sacriﬁced. Tissues were preserved in RNA-later
(Qiagen, Valencia, CA, USA, n = 12) or ﬁxed
(n = 2). The institutional animal care and use com-
mittee approved the animal studies.
Immunohistochemistry
Human ADSCs were cultured on coverslips under
normal circumstances. Cells were washed with
PBS, ﬁxed in paraformaldehyde 4% during 10
minutes, and permeabilized by incubation in 0.1%
saponin in paraformaldehyde 4% for 10 minutes.
Cells were washed, and then stained with CCR4-
FITC (R&D Systems) 1:25 in 3% goat serum and
0.1% saponin in PBS at room temperature, after
blocking with 3% goat serum and 0.1% saponin
in PBS for 30 minutes. Cells were washed twice
in PBS supplemented with 0.1% saponin, and
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actin-ﬁlaments were stained using Alexa Fluor
488-conjugated phalloidin 1:500 (Invitrogen,
Carlsbad, CA, USA) in 4% paraformaldehyde.
Nuclear staining was performed by 2-minute incu-
bation in 4′,6-diamidino-2-phenylindole (DAPI;
D-3571, Invitrogen) 1:10,000 in PBS. Coverslips
were then mounted on glass slides with ﬂuores-
cence mounting medium (Vectashield, Vector
Laboratories, Burlingame, CA, USA).
Freshly dissected rat MPGs were ﬁxed for 4
hours with cold 2% formaldehyde and 0.002%
picric acid in 0.1 M phosphate buffer, followed by
overnight immersion in buffer solution containing
30% sucrose. Tissues were frozen in optimum
cutting temperature compound (Sakura Finetek,
Torrance, CA, USA), and stored at −80°C until
use. Sections were cut at 5 μm, adhered to charged
slides, air dried for 10 minutes, and rehydrated
with PBS. Goat serum 3% in PBS was applied as
blocking agent for 30 minutes. Sections were incu-
bated overnight at 4°C with primary antibodies,
followed by 1 hour incubation in 1:500 dilution of
secondary antibody conjugated with Alexa Fluor
488 (Invitrogen) or Alexa Fluor 594 (Invitrogen).
Primary antibodies were: rabbit anti-CCL2 1:400
(Abcam Inc., Cambridge, MA, USA) and mouse
anti-4E2 1:400 (the mouse anti-rat4E2 antibody
was obtained from the Developmental Studies
Hybridoma Bank developed under the auspices of
the NICHD and maintained by The University
of Iowa, Department of Biology, Iowa City,
IA, USA). Nuclear staining was performed
by 2-minute incubation in 4′,6-diamidino-2-
phenylindole (D-3571, Invitrogen).
Quantitative Real-Time Polymerase Chain
Reaction (qPCR)
qPCR was used to identify chemokine expression
in the rat MPG after CN injury, and to test the
presence of mRNA for 21 currently known
chemokine receptors in human ADSC. MPG
tissue was lysed in Trizol (Invitrogen), ADSC cells
were lysed in RLT buffer (Qiagen, Hilden,
Germany) +1% β-mercaptoethanol (Sigma-
Aldrich). mRNA was isolated from tissue or cell
lysates using the RNeasy mini kit (Qiagen S.A.,
Courtaboeuf, France) and reverse transcribed
using a iScript cDNA synthesis kit (Bio-Rad, Her-
cules, CA, USA). The ampliﬁcation was per-
formed using TaqMan™ primer sets in Tables 1
and 2 and the TaqMan™ Universal Fast Master
Mix (Applied Biosystems, Carlsbad, CA, USA) on
an ABI7900HT System (Applied Biosystems).
Normalization of the cycle threshold data was
done to reference genes including GADPH,
GUSB, 18S, and HPRT1 for ADSC, and beta-
actin for the MPG.
Functional Assays on ADSC
Primers for the investigation of the MPG
were based on chemokine receptor expression
(qPCR and FACS, see above) in human ADSC.
Chemokines that were found to be upregulated
in the MPG following injury were acquired in
human recombinant form and applied for further
functional testing of ADSC: CCL28 (binds to
CCR10), CCL19 (CCR7, included as additional
negative control based on qPCR and FACS),
CCL2 (CCR4), CXCL12 (CXCR4), CX3CL1
(CX3CR1), and XCL1 (XCR1) (R&D Systems).
Acquired human recombinant chemokines were
then used for functional testing as described next
under “ADSC Migration Assay” and “ADSC
Calcium Imaging Assay.”
ADSC Migration Assay
Passage 5 human ADSCs were allowed to reach
90% conﬂuence in DMEM containing 10% FBS
in a 96-well Oris cell migration assay plate (Platy-
pus Technologies, Fitchburg, WI, USA) equipped
Table 1 Expression of chemokine and cytokine mRNA in the rat MPG in sham and cavernous nerve-injury animals.
Gene (rat) NCBI RefSeq
Amplicon
length Fold exp. SHAM Fold exp. CN-injury t-Test
TGF-β1 NM_021578.2 65 1,262 ± 0,23 11,464 ± 2,83 P = 0.024
TGF-β2 NM_031131.1 95 0,059 ± 0,01 0,295 ± 0,02 P < 0.001
TGF-β3 NM_013174.2 61 4,120 ± 1,73 26,23 ± 11,47 P = 0.08
TNF-α NM_012675.3 82 0,001 ± 0,00 0,007 ± 0,00 P = 0.042
CCL2 NM_031530.1 95 0,723 ± 0,03 5,278 ± 0,38 P = 0.002
CCL28 NM_053700.1 66 0,001 ± 0,00 0,017 ± 0,01 P = 0.122
CXCL12 NM_001033882.1 60 10,037 ± 2,02 50,745 ± 10,2 P = 0.003
CX3CL1 NM_134455.1 74 0,193 ± 0,02 1,494 ± 0,11 P < 0.001
XCL1 NM_134361.1 89 0,293 ± 0,03 0,855 ± 0,16 P = 0.004
Bold font indicates statistically signicant values.
MPG = major pelvic ganglion.
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with central stoppers preventing from cells to
attach in a central detection area. The medium
was then replaced with chemokine-supplemented
DMEM in dosages of 1 nM, 100 nM, and 10 μM.
Following incubation, the central stopper was
removed and the cells were allowed to migrate
toward the central detection zone for 24 hours. As
a negative control, DMEM lacking FBS was used,
while DMEM + 10% FBS was used as a positive
control. Cell migration was quantiﬁed digitally by
Image J software (NIH, Bethesda, MD, USA) on
images taken of the central detection area after
application of a detection mask.
ADSC Calcium Imaging Assay
Previous to the measurements, cells were
incubated with 2 μM Fura-2AM ester (Biotium,
Hayward, CA, USA) for 30 minutes at 37°C.
Intracellular Ca2+ concentration was measured on
a monochromator-based imaging system consist-
ing of a Polychome IV monochromator (Till Pho-
tonics, Martinsried, Germany) and a CCD camera
(Roper Scientiﬁc, Tucson, AZ, USA) connected
to a Zeiss Axiovert 200 M inverted microscope
(Oberkochen, Germany). Fluorescence was mea-
sured during excitation at 340 and 380 nm, and
after correction for the individual background
ﬂuorescence signals, the ratio of the ﬂuorescence
at both excitation wavelengths (F340/F380) was
monitored, as a measure for intracellular calcium
concentrations. Experiments were performed
using standard Krebs solution. All the investigated
chemokines were dissolved in Krebs solution at
50 nM and cells were exposed for 2 minutes, fol-
lowed by a washout period of 3–5 minutes.
Ionomycin 10 μM was used as a positive control at
termination of the experiment.
Results
Isolation of ADSC, Characterization, and Multilineage
Differentiation Capacity
ADSCs were successfully isolated from the har-
vested adipose tissue of all three donors and
Table 2 Expression pattern of mRNA coding for chemokine receptors in ADSC.
Receptor NCBI RefSeq Amplicon length
Fold expression/
housekeeping genes*
CCR1 NM_001295.2 77 0,021 ± 0,01
CCR2 NM_001123041.2 77 NE
CCR3 NM_001164680.1 75 0,087 ± 0,02
CCR4 NM_005508.4 87 0,095 ± 0,01
CCR5 NM_000579.3 98 NE
CCR6 NM_004367.5 145 NE
CCR7 NM_001838.3 58 NE
CCR8 NM_005201.3 84 NE
CCR9 NM_006641.3 146 NE
CCR10 NM_016602.2 147 0,020 ± 0,00
CX3CR1 NM_001171171.1 162 0,593 ± 0,14
CXCR1 NM_000634.2 72 NE
CXCR2 NM_001168298.1 91 NE
CXCR3 NM_001142797.1 164 NE
CXCR4 NM_001008540.1 153 0,012 ± 0,01
CXCR5 No RefSeq 73 NE
CXCR6 NM_006564.1 159 0,025 ± 0,00
CXCR7 NM_020311.2 129 0,021 ± 0,00
XCR1 NM_001024644.1 61 0,065 ± 0,00
CCRL1 NM_016557.2 107 1,401 ± 0,12
CCRL2 NM_001130910.1 103 0,031 ± 0,01
*Housekeeping genes: HPRT1, GUSB, 18S, and GADPH. Detection of chemokine receptor mRNA is expressed as fold expression over the mean expression of
the four housekeeping genes per sample.
ADSC = adipose tissue-derived stem cell; NE = not expressed (CT > 40).
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formed a monolayer in approximately 1 week to 10
days after initial plating (Figure 1B).
For characterization of ADSCs, expression of
their cell surface antigens was examined by ﬂow
cytometry (Figure 1A). Cells were strongly posi-
tive for the typical MSC markers CD29, CD44,
CD73, CD90, CD105, CD166, and HLA-ABC.
While in the initial passages low positivity for
Figure 1 (A) Flow cytometry analysis on ADSCs isolated from female human donors shows the vast majority of cells express
an CD14−, CD34−, CD45−, HLA-DR− and CD29+, CD90+, CD166+, CD73+, CD105+, CD44+ HLA-ABC+ phenotype,
consistent with the typical mesenchymal multipotent stromal cell surface marker prole (light gray area: isotype control, black
line: sample). (B) Cultured human ADSCs display a typical broblast-like morphology and are able to differentiate toward
adipogenic and osteogenic lineages in vitro. Figure 1 is adapted from reference [14] with permission. ADSC = adipose
tissue-derived stem cell.
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CD34 was detected, cells were typically strictly
negative for CD14, CD34, CD45, and HLA-DR
above passage 3.
To investigate the differentiation potential of
ADSC, these cells were directed toward the
osteogenic and adipogenic lineages. The osteo-
genic differentiation was conﬁrmed by deposition
of alizarin red-staining calcium in a mineralized
matrix (Figure 1B). Adipogenic differentiation was
demonstrated by accumulation of lipid vacuoles in
cytoplasm of the cells indicated by positive Oil Red
O staining (Figure 1B). All ADSC samples showed
both osteogenic and adipogenic differentiation
capacities.
Posttraumatic Chemokine Expression in the Major
Pelvic Ganglion
Major pelvic ganglia were harvested from rats 24
hours after either sham injury or bilateral CN
injury. Following injury, we observed signiﬁcantly
elevated expression of various inﬂammatory
markers including tumor necrosis factor alpha
(TNF-α), and transforming growth factor beta
(TGF-β)1 and 2, but not the anti-inﬂammatory
isotype TGF-β3. Furthermore, the chemokines
CCL2, CXCL12, CX3CL1, and XCL1 were
elevated after injury. CCL 28 was elevated but did
not reach signiﬁcant difference compared with
sham-operated animals due to large variation in
the regulation of this chemokine and low overall
expression (Table 1). We located CCL2/MCP-1
expression in the MPG to the glia cells rather than
the neurons using immunoﬂuorescence double-
staining (Figure 2).
Chemokine Receptor mRNA in ADSCs
With a detection limit of 40 transcription cycles,
we detected presence of mRNA for the following
chemokines in human ADSC: CCR1, CCR3,
CCR4, CCR10, CXCR4, CXCR6, CXCR7,
CX3CR1, XCR1, CCRL1, CCRL2 (Table 2).
FACS of ADSCs
Other groups have noticed low surface marker
expression of chemokine receptors in MSC despite
their ability to migrate toward a gradient of the
ligands of these receptors. In standard FACS
analysis, surface marker expression of any
chemokine receptor was very low, with minor
expression for CCR4, CCR10, CXCR6, CXCR7,
CX3CR1, and XCR1. CCR1, CCR3, CCR7,
CXCR4, CCRL1, and CCRL2 were not expressed
on the cell surface of human ADSC. CCR7 was
included in this analysis as a negative control based
on absence of mRNA expression for this receptor
(Figure 3A). After cell permeabilization, however,
detection of CCR4, CCR10, CX3CR1, and XCR1
was strongly positive (signal : noise (S : N) > 5).
CCR1, CCR3, CXCR4, CXCR6, and CXCR7
were detected but displayed lower expressions
(S : N < 5). CCR7, CCRL1 and CCRL2 were
not detected in the intracellular compartment
(Figure 3B). By far, the strongest intracellular
expression was noted for CCR4. We conﬁrmed
the intracellular presence of this receptor by
immunoﬂuorescence microscopy on attached and
suspended cells (Figure 4). This investigation
showed rather low membranous and cytoplasmic
expression, and strong expression of the receptor
in the perinuclear endoplasmic reticulum, indicat-
ing active production of this receptor in attached
ADSC in culture.
ADSC Migration Assay
Chemokines generally induced migration in
a dosage-dependent fashion. FBS-supplemented
DMEM induced migration, while in the serum-
free DMEM incubated wells only few cells
Figure 2 Representative immunofluorescence image of the rat MPG 24 hours after cavernous nerve injury. Original
magnication ×400. 4E2 (red signal) is a rat-specic peripheral glia marker, and MCP1 (monocyte chemoattractant protein)
is CCL2, a chemokine. Nuclear staining was performed with DAPI (blue). Note the colocalization of MCP1 and 4E2, indicating
this chemokine is mainly expressed in glia rather than neurons. MPG = major pelvic ganglion.
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migrated into the central detection zone. In the
100 nM and 10 μM concentrations, signiﬁcantly
more cells were counted in the detection zone
when cells were treated with CCL28, CCL2,
XCL1, and CX3CL1 than when treated with
serum-free DMEM. CCL19 did not induce an
increase in cell migration compared with serum-
free medium. For CXCL12, only in the highest
concentration there was a relatively small increase
(1.71 ± 0.2-fold) of number of migrated cells com-
pared with serum-free medium (Figure 5A, B).
Calcium Imaging
Attached ADSCs were subjected to calcium
imaging to conﬁrm the functional activation of
chemokine receptors by binding of their speciﬁc
chemokines. Positive responses to administration
of 50 nM of CCL28, CCL2, XCL1, and CX3CL1
were noted. CXCL12 elicited an insigniﬁcant
response (increase in ratio fura 340/380 from base-
line <0.2). Binding of CCL19 to its receptor
CCR7 was not observed as indicated by a complete
absence of calcium inﬂux upon administration of
this chemokine (Figure 5C).
Discussion
MSCs were ﬁrst described by Friedenstein and
colleagues in 1968 as ﬁbroblast-like cells derived
from the bone marrow which generated colonies
when plated at low densities [15]. Of the various
tissues in which MSC have since been isolated, the
fat tissue has been of particular interest for ED
researchers investigating cellular therapy [16].
ADSCs are a distinct population of MSC residing
at the perivascular niche in adipose tissue [17].
They share many characteristics with BM-MSC
pertaining to morphology, phenotype, ex vivo dif-
ferentiation ability, and they have a highly similar
gene expression proﬁle [18]. However, the fre-
quency of these cells is 100 to 500-fold higher in
adipose tissue compared with the frequency of
MSC in bone marrow [4,19]. Furthermore, while
bone marrow is obtainable in the gram range by a
Figure 4 Immunofluorescence staining of human attached and suspended ADSC. (A, B) Cells were cultured on coverslips,
permeabilized using saponin, and stained against f-actin (red), CCR4 (green), and DAPI (blue). Note that the staining pattern
of CCR4 is perinuclear and morphologically consistent with expression in the endoplasmic reticulum. (C) Cells in suspension
were permeabilized using saponin and stained CCR4 (green) and DAPI (blue). Note the intracellular staining of CCR4.
ADSC = adipose tissue-derived stem cell.
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painful marrow aspiration, hundreds of grams of
adipose tissue can be obtained with minimally
invasive procedures under local anesthesia.
ADSCs have been shown to be capable of
recruitment to injured tissues after systemic
administration [20–23]. In particular, we have
recently observed ADSC recruitment toward the
MPG in the early days after injury to the CNs [12].
Likely, this recruitment process is essential, as
those rats that received ADSC injection in the
corpus cavernosum (a highly perfused system)
showed improvement of functional and structural
outcomes. In contrast, those rats in which ADSCs
were injected in the dorsal penile perineural space,
which is rather static in terms of blood ﬂow,
did not recover erectile function and showed
erectile tissue deterioration similar to untreated
rats. Strikingly, only in the group treated with
Figure 5 Functional activation of
chemokine receptors in human
ADSC. (A, B) Chemotaxis assay:
ADSCs were incubated with increas-
ing concentrations of chemokines
in standard medium. Serum-free
medium was used as a negative
control. FBS-supplemented medium
was used as a positive control (green
bar). Migration was assessed by
counting the number of cells migrated
toward the middle area of a well after
removal of a central stopper. Values
are expressed as ratio of migrated
cells over migrated cells in negative
control medium. ANOVA: +P < 0.05
compared with other concentration of
same chemokine, *P < 0.05 com-
pared with negative control, §P < 0.05
compared with all other samples.
(C) Live cell calcium imaging: ADSCs
were plated on a coverslip and
loaded with FURA2. Coverslips were
mounted in a perfusion chamber and
cells were exposed to DMEM medium
supplemented with chemokines at a
concentration of 50 nM for 2 minutes
each. The ratio of light emission
during 340/380 nM excitation was
recorded as a measure of intracellular
calcium concentrations. At conclusion
of the experiment, cell viability and
calcium influx were assessed using
ionomycin as a positive control.
n = 20–30. ADSC = adipose tissue-
derived stem cell; DMEM =
Dulbecco’s modied Eagle medium;
FBS = fetal bovine serum.
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intracavernosal injection, ADSCs were found in
the MPG early after inﬂiction of the nerve injury.
Upregulation of the chemokine CXCL12 (SDF1)
was observed and it was initially assumed that this
was an important recruitment factor for ADSC in
the MPG [12].
While CXCL12 binds to both CXCR4 and
CXCR7, the afﬁnity of CXCR4 for CXCL12 is
high and the interaction between CXCL12 and
CXCR4 has been extensively investigated and has
been a focus of cell migration research in various
disease models [22–27]. However, the expression
of this receptor on the cell surface of MSC, and
ADSC in particular, has been debated, and has
repeatedly been shown to be very low, and either
or not functional [25,28]. This led us to design the
current study as to investigate which chemokine
receptors may be play an important role in the
observed ADSC recruitment to the MPG follow-
ing injury of the CNs. CXCL12 was, as we
reported before [12], indeed expressed in the rat
MPG following CN injury as illustrated by an
upregulation of its mRNA in the MPG 1 day after
injury. There was a low but present intracellular
expression of CXCR4 in all three ADSC cell lines,
and no expression on the surface of the cells. This
structural ﬁnding was reﬂected in the functional
experiments in which CXCL12 did not elicit sig-
niﬁcant calcium inﬂux at the applied concentra-
tion, and induced ADSC migration in vitro only at
the highest concentration of CXCL12. It is there-
fore not likely an important recruitment factor for
ADSC at lower concentrations. Based on the
observations made, we have been able to match
expression of CCL28, CCL2, CX3CL1, and
XCL1 in the MPG to genomic, structural, and
functional expression and activation of their
respective receptors in ADSC by their ligands.
These data help us understand how ADSC recruit-
ment takes place and may identify targets for
improvement of stem cell recruitment and thus
potentially also treatment efﬁcacy.
Several studies have reported the structural
expression of various chemokine receptors on
human ADSC or MSC in general; some of the
results are inconsistent between research groups,
and many studies have not looked at the full panel
of chemokine receptors [28–34]. The low cell
surface expression of various chemokine receptors
has been reported before in MSC [31]. This has
been attributed to the use of trypsin-EDTA during
cell detachment [32], and of certain receptors
it has been shown that they are at least in part
residing in intracellular compartments. We now
observed that this holds true for most of the func-
tional receptors in ADSC [31]. The intracellular
localization does not appear to affect either migra-
tory capacity or activation of these receptors
results in calcium inﬂux in the cell, representing an
important step in signaling of most G-protein
coupled receptors. It should however be kept in
mind that in the functional experiments the cells
were attached and thus no trypsinization was
performed. The latter issue indicates that recep-
tors at the cell surface may still be the effectors
for the observed functional activation. Our
immunoﬂuorescence study of attached ADSC for
CCR4 localization revealed expression mainly in
the endoplasmic reticulum. Previously, a similar
observation has been made pertaining to the
intracellular expression of CXCR7 in cultured
neurons [35]. While the implications of this
ﬁnding are to date not clear, it is known that the
endoplasmic reticulum is part of the secretory
pathway implicated in protein translocation to the
cell surface, and it is commonly considered a
default pathway [35]. These data suggest that
chemokine receptors may be redirected to the cell
surface under speciﬁc cellular conditions. It may
further imply that these receptors are continuously
produced, even when cells remain in culture for
several weeks. Some authors have proposed that
ADSCs, when cultured in hypoxic conditions
or in presence of TNF-α, display a higher number
of chemokine receptors at their cell surface
[25,34,36]. The ﬁndings in our study imply that
increased cell surface expression in these condi-
tions may not only be the result of elevated tran-
scription and/or translation, but may be due to
receptor translocation to the surface of the cell
when the cell is under noxious conditions. Further
research pertaining to receptor cycling and trans-
location is currently in progress in our laboratories
to better understand these processes.
Three limitations inherent to the research may
restrict the conclusions of this study. First, while
we have studied the chemokine regulation in the
neural tissue of rats, the chemokine receptor char-
acterization was done in human cells. This is due
to limited availability for rat-speciﬁc chemokine
receptor primers and antibodies, as well as rat
recombinant proteins with commercial suppliers.
Furthermore, for evident ethical reasons, it is not
possible to harvest human hypogastric and pelvic
ganglia following radical prostatectomy. On the
other hand, it has been demonstrated that rodent
and human chemokine receptor proﬁles in stem
cells are highly similar, and our conclusions may
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thus be extended, with caution, to the rat in vivo
situation [32]. A second limitation encompasses
the fact that no in vivo recruitment experiments
with blockade or knockdown of certain ligands or
receptors were included in this study. We chose
not to perform these studies, as it is not likely that
blocking one single ligand/receptor pair would
signiﬁcantly impair recruitment as we have shown
that there are several receptors involved in these
migratory processes. Third, both chemokines
and receptors are promiscuous. We chose those
chemokines that have no or very limited known
cross-reactivity with other receptors present in the
ADSC for functional activation assays, to limit
this bias. However, although unlikely, previously
unknown cross-reactivity may occur.
In spite of these limitations, our study pro-
vides a qPCR screening of the full panel of the 21
currently known chemokine receptors, and an
in-depth structural and functional characterization
of the expressed receptors. We are, to our knowl-
edge, the ﬁrst to assess the complete chemokine
receptor expression proﬁle in human ADSC in
this detail. Furthermore, we performed calcium-
imaging experiments with chemokine stimulation
on adult stem cells to validate migration data, and
to bypass the possible bias of manual cell counting
in migration assays as a measure for functional
activation of chemokine receptors. Our ﬁndings
may further help in tailoring stem cell sources in
the function of pathophysiology of different dis-
eases with different chemokine expression proﬁles.
In addition, upregulation of chemokine receptor
expression, or translocation of known intracellular
receptors to the cell surface, may very well
improve treatment efﬁcacy of cellular therapy for
ED [34].
Conclusions
We identiﬁed the ligand/chemokine receptor pairs
CCL2/CCR4, CX3CL1/CX3CR1, and XCL1/
XCR1 as potentially responsible for ADSC
homing toward the MPG following CN injury.
While CCL28 was expressed in a low level in the
MPG before and after injury, this ligand also
induced functional activation of ADSC and its
receptor CCR10 was highly expressed by ADSC.
Surprisingly, CXCR4-CXCL12 (SDF1) interac-
tion is not likely a major homing factor for ADSC.
Modiﬁcation of expression of these receptors in
ADSC could improve migration toward injury
sites and thus treatment efﬁcacy.
Acknowledgments
M.A. is a fellow of the Research Foundation-Flanders
(FWO). D.D.R. is a fundamental-clinical researcher of
the FWO. This work was sponsored by the Federico
Foundation and the Research Foundation-Flanders
(FWO). We would like to thank Lieve Coorevits,
Carl Van Haute. and the Laboratory of Ion-channel
Research at the Catholic University of Leuven for
excellent technical assistance.
Corresponding Author:Maarten Albersen, MD, PhD,
Laboratory of Experimental Urology, University Hos-
pitals Leuven, Herestraat 49, 3000 Leuven, Belgium.
Tel: +3216346930; Fax: +3216346931; E-mail: maarten.
albersen@uzleuven.be
Conﬂict of Interest: The authors report no conﬂicts of
interest.
References
1 Boorjian SA, Eastham JA, Graefen M, Guillonneau B, Karnes
RJ, Moul JW, Schaeffer EM, Stief C, Zorn KC. A critical
analysis of the long-term impact of radical prostatectomy on
cancer control and function outcomes. Eur Urol 2012;61:664–
75.
2 Albersen M, Joniau S, Claes H, Van Poppel H. Preclinical
evidence for the beneﬁts of penile rehabilitation therapy fol-
lowing nerve-sparing radical prostatectomy. Adv Urol 2008.
doi:10.1155/2008/594868.
3 Bella AJ, Lin G, Lin C-S, Hickling DR, Morash C, Lue TF.
Nerve growth factor modulation of the cavernous nerve
response to injury. J Sex Med 2009;6(suppl 3):347–52.
4 Albersen M, Kendirci M, Van der Aa F, Hellstrom WJG, Lue
TF, Spees JL. Multipotent stromal cell therapy for cavernous
nerve injury-induced erectile dysfunction. J Sex Med
2011;9:385–403.
5 Kendirci M, Trost L, Bakondi B, Whitney MJ, Hellstrom
WJG, Spees JL. Transplantation of nonhematopoietic adult
bone marrow stem/progenitor cells isolated by p75 nerve
growth factor receptor into the penis rescues erectile function
in a rat model of cavernous nerve injury. J Urol
2010;184:1560–6.
6 Fall PA, Izikki M, Tu L, Swieb S, Giuliano F, Bernabe J,
Souktani R, Abbou C, Adnot S, Eddahibi S, Yiou R. Apoptosis
and effects of intracavernous bone marrow cell injection in a
rat model of postprostatectomy erectile dysfunction. Eur Urol
2009;56:716–25.
7 Bochinski D, Lin GT, Nunes L, Carrion R, Rahman N,
Lin CS, Lue TF. The effect of neural embryonic stem cell
therapy in a rat model of cavernosal nerve injury. BJU Int
2004;94:
904–9.
8 Meirelles LdaS, Fontes AM, Covas DT, Caplan AI. Mecha-
nisms involved in the therapeutic properties of mesenchymal
stem cells. Cytokine Growth Factor Rev 2009;20:419–27.
9 Albersen M, Fandel TM, Lin G, Wang G, Banie L, Lin C-S,
Lue TF. Injections of adipose tissue-derived stem cells and
stem cell lysate improve recovery of erectile function in a rat
model of cavernous nerve injury. J Sex Med 2010;7:3331–40.
10 Yeghiazarians Y, Zhang Y, Prasad M, Shih H, Saini SA,
Takagawa J, Sievers RE, Wong ML, Kapasi NK, Mirsky R,
Koskenvuo J, Minasi P, Ye J, Viswanathan M, Angeli FS, Boyle
AJ, Springer ML, Grossman W. Injection of bone marrow cell
14 Albersen et al.
Sex Med 2013;1:3–15 © 2013 The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Sexual Medicine.
extract into infarcted hearts results in functional improve-
ment comparable to intact cell therapy. Mol Ther 2009;17:
1250–6.
11 Zhang H, Yang R, Wang Z, Lin G, Lue TF, Lin C-S. Adipose
tissue-derived stem cells secrete CXCL5 cytokine with
neurotrophic effects on cavernous nerve regeneration. J Sex
Med 2011;8:437–46.
12 Fandel TM, Albersen M, Lin G, Qiu X, Ning H, Banie L, Lue
TF, Lin CS. Recruitment of intracavernously injected adipose-
derived stem cells to the major pelvic ganglion improves erec-
tile function in a rat model of cavernous nerve injury. Eur Urol
2011;61:201–10.
13 Albersen M, Fandel TM, Zhang H, Banie L, Lin G, De Ridder
D, Lin CS, Lue TF. Pentoxifylline promotes recovery of erec-
tile function in a rat model of postprostatectomy erectile dys-
function. Eur Urol 2011;59:286–96.
14 Castiglione F, Hedlund P, Van der Aa F, Bivalacqua TJ, Rigatti
P, Van Poppel H, Montorsi F, De Ridder D, Albersen M.
Intratunical injection of human adipose tissue-derived stem
cells prevents ﬁbrosis and is associated with improved erectile
function in a rat model of peyronie’s disease. Eur Urol
2012;63:551–60.
15 Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP.
Heterotopic of bone marrow. Analysis of precursor cells
for osteogenic and hematopoietic tissues. Transplantation
1968;6:230–47.
16 Zhang H, Albersen M, Jin X, Lin G. Stem cells: Novel players
in the treatment of erectile dysfunction. Asian J Androl
2012;14:145–55.
17 Lin C-S, Xin Z-C, Deng C-H, Ning H, Lin G, Lue TF.
Deﬁning adipose tissue-derived stem cells in tissue and in
culture. Histol Histopathol 2010;25:807–15.
18 Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, Bae YC,
Jung JS. Characterization and expression analysis of
mesenchymal stem cells from human bone marrow and
adipose tissue. Cell Physiol Biochem 2004;14:311–24.
19 Casteilla L, Planat-Benard V, Laharrague P, Cousin B.
Adipose-derived stromal cells: Their identity and uses in clini-
cal trials, an update. World J Stem Cells 2011;3:25–33.
20 Lamfers M, Idema S, van Milligen F, Schouten T, van der Valk
P, Vandertop P, Dirven C, Noske D. Homing properties
of adipose-derived stem cells to intracerebral glioma and
the effects of adenovirus infection. Cancer Lett 2009;274:78–
87.
21 Kim U, Shin D-G, Park J-S, Kim Y-J, Park S-I, Moon Y-M,
Jeong K-S. Homing of adipose-derived stem cells to
radiofrequency catheter ablated canine atrium and differentia-
tion into cardiomyocyte-like cells. Int J Cardiol 2011;146:
371–8.
22 Lin G, Wang G, Banie L, Ning H, Shindel AW, Fandel TM,
Lue TF, Lin CS. Treatment of stress urinary inconOtinence
with adipose tissue-derived stem cells. Cytotherapy 2010;12:
88–95.
23 Bobis-Wozowicz S, Miekus K, Wybieralska E, Jarocha D,
Zawisz A, Madeja Z, Majka M. Genetically modiﬁed adipose
tissue-derived mesenchymal stem cells overexpressing CXCR4
display increased motility, invasiveness, and homing to bone
marrow of NOD/SCID mice. Exp Hematol 2011;39:686–
96.e4.
24 Cho HH, Kyoung KM, Seo MJ, Kim YJ, Bae YC, Jung
JS. Overexpression of CXCR4 increases migration and prolif-
eration of human adipose tissue stromal cells. Stem Cells Dev
2006;15:853–64.
25 Hung S-C, Pochampally RR, Hsu S-C, Sanchez C, Chen S-C,
Spees J, Prockop DJ. Short-term exposure of multipotent
stromal cells to low oxygen increases their expression of
CX3CR1 and CXCR4 and their engraftment in vivo. PloS
ONE 2007;2:e416.
26 Liu X, Duan B, Cheng Z, Jia X, Mao L, Fu H, Che Y, Ou L,
Liu L, Kong D. SDF-1/CXCR4 axis modulates bone marrow
mesenchymal stem cell apoptosis, migration and cytokine
secretion. Protein & Cell 2011;2:845–54.
27 Lin G, Yang R, Banie L, Wang G, Ning H, Li L-C, Lue TF,
Lin CS. Effects of transplantation of adipose tissue-derived
stem cells on prostate tumor. Prostate 2010;70:1066–73.
28 Thangarajah H, Vial IN, Chang E, El-Ftesi S, Januszyk M,
Chang EI, Paterno J, Neofytou E, Longaker MT, Gurtner
GC. IFATS collection: Adipose stromal cells adopt a
proangiogenic phenotype under the inﬂuence of hypoxia. Stem
Cells 2009;27:266–74.
29 Baek SJ, Kang SK, Ra JC. In vitro migration capacity of human
adipose tissue-derived mesenchymal stem cells reﬂects their
expression of receptors for chemokines and growth factors.
Exp Mol Med 2011;43:596–603.
30 Ahmadian Kia N, Bahrami AR, Ebrahimi M, Matin MM,
Neshati Z, Almohaddesin MR, Aghdami N, Bidkhori HR.
Comparative analysis of chemokine receptor’s expression in
mesenchymal stem cells derived from human bone marrow and
adipose tissue. J Mol Neurosci 2011;44:178–85.
31 Brooke G, Tong H, Levesque J-P, Atkinson K. Molecular
trafﬁcking mechanisms of multipotent mesenchymal stem cells
derived from human bone marrow and placenta. Stem Cells
Dev 2008;17:929–40.
32 Chamberlain G, Wright K, Rot A, Ashton B, Middleton J.
Murine mesenchymal stem cells exhibit a restricted repertoire
of functional chemokine receptors: Comparison with human.
PloS ONE 2008;3:e2934.
33 Chamberlain G, Fox J, Ashton B, Middleton J. Concise review:
Mesenchymal stem cells: Their phenotype, differentiation
capacity, immunological features, and potential for homing.
Stem Cells 2007;25:2739–49.
34 Ponte AL, Marais E, Gallay N, Langonné A, Delorme B,
Hérault O, Charbord P, Domenech J. The in vitro migration
capacity of human bone marrow meseSnchymal stem cells:
Comparison of chemokine and growth factor chemotactic
activities. Stem Cells 2007;25:1737–45.
35 Shimizu S, Brown M, Sengupta R, Penfold ME, Meucci O.
CXCR7 protein expression in human adult brain and differen-
tiated neurons. PloS ONE 2011;6:e20680.
36 Tang YL, Zhu W, Cheng M, Chen L, Zhang J, Sun T, Kishore
R, Phillips MI, Losordo DW, Qin G. Hypoxic precondition-
ing enhances the beneﬁt of cardiac progenitor cell therapy for
treatment of myocardial infarction by inducing CXCR4
expression. Circ Res 2009;104:1209–16.
Chemokines in ADSC Migration to the MPG 15
Sex Med 2013;1:3–15© 2013 The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Sexual Medicine.
